Generated: October 17, 2017
DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 072397
, which is a drug marketed by Martec Usa Llc, Upsher-smith Labs, Ferndale Labs, Actavis Elizabeth, Ivax Sub Teva Pharms, West-ward Pharms Int, Warner Chilcott, Watson Labs, Parenta Pharms, Us Army, Mylan, Dava Pharms Inc, Lannett Holdings Inc, Mayne Pharma, Vintage Pharms, Barr, Teva Pharms, Halsey, Roxane, Abraxis Pharm, Virtus Pharms, Watson Labs Inc, Marsam Pharms Llc, Pioneer Pharms, Hospira, and Duramed Pharms Barr, and is included in seventy-one NDAs. It is available from forty-seven suppliers. Additional details are available on the DIAZEPAM profile page.
The generic ingredient in DIAZEPAM is diazepam. There are eight drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the diazepam profile page.
Summary for NDA: 072397
|Formulation / Manufacturing:||see details|Complete Access Available with Subscription
Summary for product number 001
|Approval Date:||Jan 29, 1993||TE:||RLD:||No|
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.